Can-Fite BioPharma Ltd. EV/EBITDA Ratio 2011-2026 | CANF

Annual EV/EBITDA Ratio Can-Fite BioPharma Ltd.

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-43.1	-1.08	-19.2	105	243	109	146	34.2	-3.25	-4.2	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
243	-43.1	56.5

EV/EBITDA Ratio of other stocks in the Biotechnology industry

Issuer	EV/EBITDA Ratio	Price	% 24h	Market Cap	Country
Acorda Therapeutics ACOR	0.777	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	1.8	-	4.01 %	$ 150 M	Canada
MorphoSys AG MOR	-0.591	-	2.43 %	$ 254 M	Germany
ARCA biopharma ABIO	1.84	-	1052.0 %	$ 415 M	USA
Albireo Pharma ALBO	-3.38	-	-0.23 %	$ 916 M	USA
Adagene ADAG	-4.92	$ 2.81	-3.61 %	$ 158 M	China
Biogen BIIB	12.7	$ 176.6	0.24 %	$ 25.7 B	USA
BioNTech SE BNTX	4.1	$ 114.69	-1.78 %	$ 27.2 B	Germany
ANI Pharmaceuticals ANIP	109	$ 80.99	-1.23 %	$ 1.56 B	USA
Alexion Pharmaceuticals, Inc. ALXN	10.7	-	-	$ 40.3 B	USA
Amgen AMGN	10.7	$ 340.73	-0.64 %	$ 183 B	USA
Aeglea BioTherapeutics AGLE	-4.27	-	-	$ 1.01 B	USA
Biophytis SA BPTS	-17.6	-	-13.47 %	$ 169 M	France
Midatech Pharma plc MTP	0.796	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	-3.42	-	-1.52 %	$ 24.7 M	USA
Aytu BioScience AYTU	-1.92	$ 2.59	0.39 %	$ 16.3 M	USA
CASI Pharmaceuticals CASI	-26.1	$ 0.99	-0.01 %	$ 135 M	USA
Alterity Therapeutics Limited ATHE	-0.994	$ 3.25	-0.35 %	$ 7.82 B	Australia
Akero Therapeutics AKRO	-4.64	-	-	$ 3.67 B	USA
Catalyst Biosciences CBIO	0.34	$ 9.72	-4.19 %	$ 640 M	USA
Allena Pharmaceuticals ALNA	0.298	-	3.16 %	$ 1.9 M	USA
AVROBIO AVRO	0.957	-	1083.1 %	$ 745 M	USA
Cerus Corporation CERS	-24.7	$ 2.25	-3.02 %	$ 415 M	USA
Aptose Biosciences APTO	388	-	-45.71 %	$ 1.2 M	Canada
Aravive ARAV	-0.158	-	-13.39 %	$ 1.45 M	USA
Cellectis S.A. CLLS	-1.37	$ 3.91	-2.03 %	$ 116 M	France
Brickell Biotech BBI	0.668	-	-5.38 %	$ 6.06 M	USA
Applied Molecular Transport AMTI	-1.19	-	-	$ 10.1 M	USA
Beam Therapeutics BEAM	-11.7	$ 28.22	-3.65 %	$ 2.32 B	USA
Институт стволовых клеток человека ISKJ	14	-	-	-	Russia
Ascendis Pharma A/S ASND	-15.7	$ 223.02	-0.42 %	$ 5 B	Danmark
Athira Pharma ATHA	-3.66	-	-	$ 269 M	USA
Atreca BCEL	-2.76	-	-11.76 %	$ 5.79 M	USA
Catalyst Pharmaceuticals CPRX	7.16	$ 24.39	-0.77 %	$ 2.89 B	USA
Arrowhead Pharmaceuticals ARWR	-30.8	$ 68.44	-0.98 %	$ 9.15 B	USA
Cardiff Oncology CRDF	-8.15	$ 1.69	4.77 %	$ 80.5 M	USA
Aeterna Zentaris AEZS	4.4	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	-1.85	-	-10.17 %	$ 12.2 K	USA
Akouos AKUS	-1.13	-	0.23 %	$ 488 M	USA
Bellicum Pharmaceuticals BLCM	1.13	-	-9.72 %	$ 5.89 M	USA
Adaptimmune Therapeutics plc ADAP	-12.7	-	-15.15 %	$ 60.3 M	Britain
Berkeley Lights BLI	-16.9	-	-7.31 %	$ 87 M	USA
Amneal Pharmaceuticals AMRX	1.63	$ 13.91	-1.45 %	$ 4.3 B	USA
AIkido Pharma AIKI	-45.5	-	1.93 %	$ 17.4 M	USA
Bellerophon Therapeutics BLPH	0.0235	-	-74.18 %	$ 955 K	USA
CureVac N.V. CVAC	-7.74	-	-	$ 867 M	Germany
Acer Therapeutics ACER	-3.39	-	2.71 %	$ 14 M	USA
Alpine Immune Sciences ALPN	-5.5	-	-	$ 2.17 B	USA